EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

To Be or Not to Be: Amiodarone as Both Savior and Foe—A Therapeutic Paradox in Atrial Fibrillation Management and Ventricular Arrhythmia Associated with Amiodarone-Induced Thyrotoxicosis

Monika Amielan, Małgorzata Zalewska-Adamiec iD, Hanna Bachórzewska-Gajewska, Sławomir Dobrzycki

Life · 08.07.2026 · 16 (7) · 1134

DOI: 10.3390/life16071134 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Life, online erschienen am 08.07.2026. Verfasst von Monika Amielan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Invasive Cardiology, Internal Medicine with CICU and Laboratory of Hemodynamics, University Hospital in Bialystok, 15-089 Bialystok, Po…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amiodarone-induced thyrotoxicosis (AIT) is a serious thyroid dysfunction that represents a significant complication of pharmacological therapy in cardiology patients. The development of AIT can substantially complicate the management of cardiac arrhythmias, posing a major clinical challenge. We present the case of a patient in whom amiodarone was initially effective in the treatment of atrial fibrillation but subsequently led to type II amiodarone-induced thyrotoxicosis and exacerbation of the atrial arrhythmia. This case highlights the need for regular monitoring of patients treated with amiodarone, the challenges of managing arrhythmias in the setting of AIT, and the importance of close collaboration between cardiologists and endocrinologists in the diagnosis and treatment of AIT.

Schlagwörter

Stichwörter der Autor:innen

amiodaroneamiodarone-induced thyrotoxicosisatrial fibrillationthyrotoxicosis

Autor:innen und Institutionen

  • Department of Invasive Cardiology, Internal Medicine with CICU and Laboratory of Hemodynamics, University Hospital in Bialystok, 15-089 Bialystok, Poland.
  • Department of Invasive Cardiology, Internal Medicine with CICU and Laboratory of Hemodynamics, Medical University of Bialystok, 15-089 Bialystok, Poland.

ORCID-Profile: Małgorzata Zalewska-Adamiec

Zitieren

APA

Amielan, M., Zalewska-Adamiec, M., Bachórzewska-Gajewska, H., & Dobrzycki, S. (2026). To Be or Not to Be: Amiodarone as Both Savior and Foe—A Therapeutic Paradox in Atrial Fibrillation Management and Ventricular Arrhythmia Associated with Amiodarone-Induced Thyrotoxicosis. Life, 16(7), 1134. https://doi.org/10.3390/life16071134

Vancouver

Amielan M, Zalewska-Adamiec M, Bachórzewska-Gajewska H, Dobrzycki S. To Be or Not to Be: Amiodarone as Both Savior and Foe—A Therapeutic Paradox in Atrial Fibrillation Management and Ventricular Arrhythmia Associated with Amiodarone-Induced Thyrotoxicosis. Life. 2026;16(7):1134. doi:10.3390/life16071134

BibTeX
@article{Amielan2026,
  author = {Amielan, Monika and Zalewska-Adamiec, Małgorzata and Bachórzewska-Gajewska, Hanna and Dobrzycki, Sławomir},
  title = {To Be or Not to Be: Amiodarone as Both Savior and Foe—A Therapeutic Paradox in Atrial Fibrillation Management and Ventricular Arrhythmia Associated with Amiodarone-Induced Thyrotoxicosis},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {1134},
  doi = {10.3390/life16071134}
}
Kostenlos starten →